Comparison of the Effectiveness of Once-Daily Alogliptin/Metformin and Twice-Daily Anagliptin/Metformin Combination Tablet in a Randomized, Parallel-Group, Open-Label Trial in Japanese Patients with Type 2 Diabetes

被引：0
|
作者：
Shunsuke Yamazaki
Tatsuro Takano
Koji Tachibana
Soichiro Takeda
Yasuo Terauchi
机构：
[1] Fujisawa City Hospital,Department of Diabetes and Endocrinology
[2] Fujisawa Ekimae Diabetes and Thyroid Clinic,Department of Endocrinology and Metabolism
[3] Yokohama City University Graduate School of Medicine,undefined
来源：
Diabetes Therapy | 2022年 / 13卷
关键词：
Alogliptin; Anagliptin; Combination tablet; Dose frequency; Metformin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1559 / 1569
页数：10
相关论文
共 50 条
  • [1] Comparison of the Effectiveness of Once-Daily Alogliptin/Metformin and Twice-Daily Anagliptin/Metformin Combination Tablet in a Randomized, Parallel-Group, Open-Label Trial in Japanese Patients with Type 2 Diabetes
    Yamazaki, Shunsuke
    Takano, Tatsuro
    Tachibana, Koji
    Takeda, Soichiro
    Terauchi, Yasuo
    DIABETES THERAPY, 2022, 13 (08) : 1559 - 1569
  • [2] Different daily glycemic profiles after switching from once-daily alogliptin plus twice-daily metformin to their once-daily fixed-dose combination in Japanese type 2 diabetic patients
    Takahara, Mitsuyoshi
    Shiraiwa, Toshihiko
    Katakami, Naoto
    Maeno, Yoshifumi
    Yamamoto, Kaoru
    Shiraiwa, Yuka
    Yoshida, Yoko
    Matsuoka, Taka-Aki
    Shimomura, Iichiro
    ENDOCRINE JOURNAL, 2019, 66 (01) : 11 - 17
  • [3] Comparison of Once-Daily Bemiparin with Twice-Daily Enoxaparin for Acute Deep Vein Thrombosis: A Multicenter, Open-Label, Randomized Controlled Trial
    Igor A. Suchkov
    Javier Martinez-Gonzalez
    Sebastian M. Schellong
    Toni Garbade
    Michela Falciani
    Clinical Drug Investigation, 2018, 38 : 181 - 189
  • [4] Comparison of Once-Daily Bemiparin with Twice-Daily Enoxaparin for Acute Deep Vein Thrombosis: A Multicenter, Open-Label, Randomized Controlled Trial
    Suchkov, Igor A.
    Martinez-Gonzalez, Javier
    Schellong, Sebastian M.
    Garbade, Toni
    Falciani, Michela
    CLINICAL DRUG INVESTIGATION, 2018, 38 (02) : 181 - 189
  • [5] Once-Weekly Exenatide Versus Once- or Twice-Daily Insulin Detemir Randomized, open-label, clinical trial of efficacy and safety in patients with type 2 diabetes treated with metformin alone or in combination with sulfonylureas
    Davies, Melanie
    Heller, Simon
    Sreenan, Seamus
    Sapin, Helene
    Adetunji, Omolara
    Tahbaz, Arash
    Vora, Jiten
    DIABETES CARE, 2013, 36 (05) : 1368 - 1376
  • [6] Pharmacokinetics for Once-Daily Versus Twice-Daily Tacrolimus Formulations in De Novo Liver Transplantation: A Randomized, Open-Label Trial
    Fischer, Lutz
    Trunecka, Pavel
    Gridelli, Bruno
    Roy, Andre
    Vitale, Alessandro
    Valdivieso, Andres
    Varo, Evaristo
    Seehofer, Daniel
    Lynch, Stephen
    Samuel, Didier
    Ericzon, Bo-Goran
    Boudjema, Karim
    Karpf, Carmen
    Undre, Nasrullah
    LIVER TRANSPLANTATION, 2011, 17 (02) : 167 - 177
  • [7] Once-Daily versus Twice-Daily Tacrolimus in Living Kidney Transplantation: A Multicenter, Parallel Group, Open-Label, 5-Year, Randomized Non-Inferiority Trial
    Unagami, K.
    Okumi, M.
    Hirai, T.
    Toki, D.
    Shirakawa, H.
    Shimizu, T.
    Omoto, K.
    Inui, M.
    Ishida, H.
    Nitta, K.
    Tanabe, K.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 741 - 742
  • [8] Once-Daily versus Twice-Daily Tacrolimus in De Novo Living Kidney Transplantation Patients: A Multicenter, Parallel Group, Open-Label, 5-Year Randomized Noninferiority Trial.
    Kakuta, Y.
    Okumi, M.
    Unagami, K.
    Furusawa, M.
    Ishida, H.
    Tanabe, K.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 677 - 677
  • [9] Efficacy and safety of lixisenatide once-daily versus exenatide twice-daily in patients with type 2 diabetes insufficiently controlled on metformin (GetGoal-X)
    Rosenstock, J.
    Raccah, D.
    Koranyi, L.
    Maffei, L.
    Boka, G.
    Miossec, P.
    Gerich, J. E.
    DIABETOLOGIA, 2011, 54 : S317 - S318
  • [10] Comparison of biphasic insulin aspart 30 given three times daily or twice daily in combination with metformin versus oral antidiabetic drugs alone in patients with poorly controlled type 2 diabetes: A 16-week, randomized, open-label, parallel-group trial conducted in Russia
    Ushakova, Olga
    Sokolovskaya, Vera
    Morozova, Alla
    Valeeva, Farida
    Zanozina, Olga
    Sazonova, Olga
    Zhadanova, Elena
    Starceva, Maria
    Kazakova, Elena
    Saifullina, Marina
    Shapiro, Irina
    Tarasov, Alexander
    Al-Tayar, Bassam
    Starkova, Ninella
    CLINICAL THERAPEUTICS, 2007, 29 (11) : 2374 - 2384
12345